Ignite Creation Date:
2025-12-25 @ 4:19 AM
Ignite Modification Date:
2026-06-13 @ 7:39 AM
Study NCT ID:
NCT00374920
Status:
COMPLETED
Last Update Posted:
2008-05-06
First Post:
2006-09-09
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Safety and Efficacy of MEM 1003 Versus Placebo for the Treatment of Patients With Bipolar I Disorder
Sponsor:
Memory Pharmaceuticals
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
MEM 1003-101
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Amy S. Domanowski, Ph.D., Head Regulatory Affairs
Old Organization:
Memory Pharmaceuticals Corp.
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | OTHER | View |